Release 4B

This page is part of the FHIR Specification (v4.3.0: R4B - STU). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4

Plandefinition-opioidcds-11

Clinical Decision Support Work Group

Maturity Level: N/A

Standards Status: Informative

Compartments: Not linked to any defined compartments

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile PlanDefinition.

Generated Narrative

Resource "opioidcds-11"

url: http://hl7.org/fhir/ig/opioid-cds/PlanDefinition/opioidcds-11

identifier: id: cdc-opioid-guidance (OFFICIAL)

version: 0.1.0

name: cdc-opioid-11

title: CDC Opioid Prescribing Guideline Recommendation #11

type: ECA Rule (PlanDefinitionType#eca-rule)

status: draft

date: 2018-03-19

publisher: Centers for Disease Control and Prevention (CDC)

description: Concurrently prescribing opioid medications with benzodiazepines increases the risk of harm for the patient.

jurisdiction: United States of America (unknown#US)

purpose: CDC’s Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.

usage: Clinicians should avoid prescribing opioid pain medication and benzodiazepines concurrently whenever possible.

topic: Opioid Prescribing ()

author: Kensaku Kawamoto, MD, PhD, MHS: , Bryn Rhodes: , Floyd Eisenberg, MD, MPH: , Robert McClure, MD, MPH:

library: http://example.org/fhir/Library/opioidcds-recommendation-11

action
title: Existing patient has concurrent opioid and benzodiazepine prescriptions.
description: Checking if the trigger prescription meets the inclusion criteria for recommendation #11 workflow.
condition
kind: applicability
groupingBehavior: visual-group
selectionBehavior: exactly-one
dynamicValue
path: action.description
dynamicValue
path: action.title
dynamicValue
path: action.extension
Actions
- Description
* Will revise
* Risk of overdose carefully considered and outweighed by benefit; snooze 3 mo
* N/A - see comment; snooze 3 mo

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.